Back to competency map

Clinical competency

Facilitate integration of experience into behavioral change

Cluster covering 2 related competencies including: Integration of psychedelic experience with behavior change, Facilitate integration of experience into behavioral change.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

4

Courses

0

Providers

0

Protocols

2

Classification

Protocol families

Source quality

Lab manualProtocol paperTrial supplement

Also known as

Integration of psychedelic experience into therapyIntegration of psychedelic experience with behavior changeSupport behavior change in substance use disorder treatment

Across the manuals

The manuals converge on the idea that psychedelic sessions are not complete in themselves, but need a post-session phase that turns acute experience into longer-term change. Across the extracts, integration is described as linking insights, subjective effects, or session meanings to ongoing therapy, with a clear emphasis on reflection, consolidation, and translating experience into real-world behaviour. They also agree that this process should connect to concrete life domains. The sources repeatedly mention behaviour change, daily practices, habits, interpersonal behaviour, and, in the alcohol-focused manuals, reductions in heavy drinking, abstinence or reduced drinking, and broader alcohol-related therapeutic change. Several manuals also frame integration as tied to values, psychological flexibility, and future actions, rather than as reflection alone. The manuals differ in emphasis and framing. The psilocybin depression trial places more weight on ACT concepts, such as acceptance, defusion, self-transcendence, and values clarity, and explicitly includes termination and aftercare planning. The alcohol use disorder manuals focus more narrowly on substance use outcomes and remission, while the 5-MeO-DMT source is broader and more general, stressing meaning-making, self-improvement, inner peace, and integration into ongoing mental health care. The 2025 alcohol and depressive symptoms trial also stands out for its process detail, including free narration, a nonjudgmental and noninterpretive stance, and linking insights back to the patient’s original intentions.

Synthesised from the linked source documents; refreshed as the library updates.

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (4)

  • 5-MeO-DMT: Potential Use of Psychedelic-Induced Experiences in the Treatment of Psychological Disorders

    5-MeO-DMTEvidence score: 90

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.